Neuropathology Core
Neuropathology Core
批准号:
10615167
负责人:
Robert A Rissman
金额:
$31.24万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-05-01 至 2024-03-31
关键词:
Alzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease pathologyAnimal ModelAutopsyBiochemistryBlood VesselsBrainC9ORF72CellsCessation of lifeClinicalCollaborationsCollectionDataDementiaDementia with Lewy BodiesDiagnosisDiagnosticDiseaseDocumentationEducationEquipment and supply inventoriesEvaluationEyeFacultyFosteringFrontotemporal DementiaFundingGene ExpressionGenetic DiseasesGenetic TranscriptionGenetic VariationGuidelinesImmunohistochemistryInformaticsInternationalLewy Body DiseaseMentorsMethodsMicroscopyMissionNational Institute on Alcohol Abuse and AlcoholismNerve DegenerationNeurodegenerative DisordersNeuronsPaperParticipantPathogenesisPathologicPathologyPatientsPhilanthropic FundProceduresProcessProteinsProtocols documentationPublishingResearchResearch PersonnelResearch Project GrantsResearch SupportResource SharingResourcesRoleSamplingScanningScientistSeriesSkinSlideSpecimenSpinal CordStandardizationStudentsSynapsesSystemTauopathiesTechniquesTissue BanksTissue SampleTissuesTrainingage relatedagedalpha synucleinbiobankbrain tissueclinical diagnosisdata managementdementedexosomefrontotemporal lobar dementia amyotrophic lateral sclerosisgenome-wide analysisgraduate studentinduced pluripotent stem cellinterestmeetingsminority investigatorminority scientistneuropathologynext generationnoveloutreachparticipant enrollmentprotein TDP-43recruitrepositorysymposiumsynucleinopathytau Proteinstranscriptomicsundergraduate studentworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
NEUROPATHOLOGY CORE - SUMMARY/ ABSTRACT
For the past 35 years, the UCSD-ADRC Neuropathology Core has been instrumental in providing support
for establishing the accuracy of clinical diagnosis of Alzheimer's Disease (AD) and dementia with Lewy bodies
(DLB), delineating structural and clinico-pathological correlates of dementia in AD, identifying new
neuropathological entities causing dementia, providing tissues to investigators and helping to better
understand the mechanisms of synaptic and other aspects of neurodegeneration in AD. For the renewal there
will be 6 Aims of the Neuropathology Core: 1) perform rapid autopsies and procure brains from the ADRC
participants, using a standardized protocol; 2) perform standardized neuropathological diagnoses and
immunocytochemical analysis of demented and normal aged (control) patients clinically evaluated by the
UCSD ADRC following the new NIA criteria; 3) perform clinical neuropathology assessments on brain, spinal
cords and eyes from postmortem material from ADRC participants using best practice (NIA-AA) guidelines.
Perform immunochemical analysis relevant to neurodegeneration and synapse loss in MCI and early AD
cases; 4) maintain a state of the art brain repository to provide the ADRC projects and other investigators with
well characterized including early AD and MCI cases; 5) foster the utilization of the ADRC Neuropathology
tissue repository for new research and inter-center collaborations. Approximately 50 to 60 cases and over 100
tissue requests are processed a year. The neuropathological results will be submitted to the National
Alzheimer’s Coordinating Committee (NACC) in compliance with NIA requirements. As part of the mission of
the Core we will also continue to support extensive collaborations with national and international investigators
and train fellows, residents, graduate and undergraduate students in neuropathology and microscopy
techniques. With the ADRC Outreach, Recruitment and Education (ORE) Core organize meetings to
encourage the use of the neuropathology core; 6) Mentor young and minority investigators in neuropathology
and neuropathological research. We will foster the next generation of scientists by encouraging them to
conduct research with the postmortem tissues. We will continue to provide tissues to local and national
investigators and for multi-center initiatives such as the Genome-Wide Analysis Studies organized by NIA.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HABS-HD - Core D - Omics Core
-
批准号:10493848
-
项目类别:
-
资助金额:$918.05万
-
财政年份:2022
-
负责人:Robert A Rissman
-
依托单位:
Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies
-
批准号:10186335
-
项目类别:
-
资助金额:$175.11万
-
财政年份:2021
-
负责人:Robert A Rissman
-
依托单位:
Novel Antagonists of the N-terminal Domain of the CRF Receptor Type 1 for Alzheimer's Disease
-
批准号:10433769
-
项目类别:
-
资助金额:$35.45万
-
财政年份:2020
-
负责人:Robert A Rissman
-
依托单位:
Neuropathology Core
-
批准号:10407982
-
项目类别:
-
资助金额:$29.22万
-
财政年份:2019
-
负责人:Robert A Rissman
-
依托单位:
Biomarker Core
-
批准号:10615171
-
项目类别:
-
资助金额:$23.22万
-
财政年份:2019
-
负责人:Robert A Rissman
-
依托单位:
Biomarker Core
-
批准号:10407984
-
项目类别:
-
资助金额:$21.82万
-
财政年份:2019
-
负责人:Robert A Rissman
-
依托单位:
Proteomic characterization of exosomes from AD patients
-
批准号:9563205
-
项目类别:
-
资助金额:$84.4万
-
财政年份:2017
-
负责人:Robert A Rissman
-
依托单位:
Pathogenicity of neuronally-derived tau in exosomes
-
批准号:9336219
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2016
-
负责人:Robert A Rissman
-
依托单位:
Validation Studies of CRF Receptor 1 as a Target for AD
-
批准号:9325287
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Robert A Rissman
-
依托单位:
Polytherapy for AD: Combining Gamma-secretase Modulation and CRFR1 Antagonism
-
批准号:8771201
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2014
-
负责人:Robert A Rissman
-
依托单位:
Polytherapy for AD: Combining Gamma-secretase Modulation and CRFR1 Antagonism
-
批准号:8917840
-
项目类别:
-
资助金额:$22.55万
-
财政年份:2014
-
负责人:Robert A Rissman
-
依托单位:
Stress and CRF Signaling in Alzheimer?s Disease Pathogenesis
-
批准号:7898638
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2008
-
负责人:Robert A Rissman
-
依托单位:
Stress and CRF Signaling in Alzheimer?s Disease Pathogenesis
-
批准号:7508580
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2008
-
负责人:Robert A Rissman
-
依托单位:
Stress and CRF Signaling in Alzheimer?s Disease Pathogenesis
-
批准号:7673344
-
项目类别:
-
资助金额:$40.09万
-
财政年份:2008
-
负责人:Robert A Rissman
-
依托单位:
Stress and CRF Signaling in Alzheimer?s Disease Pathogenesis
-
批准号:8105068
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2008
-
负责人:Robert A Rissman
-
依托单位:
Stress and CRF Signaling in Alzheimer?s Disease Pathogenesis
-
批准号:8309237
-
项目类别:
-
资助金额:$36.37万
-
财政年份:2008
-
负责人:Robert A Rissman
-
依托单位:
Role of Intracellular ABeta in Tau Pathology
-
批准号:6738775
-
项目类别:
-
资助金额:$4.16万
-
财政年份:2004
-
负责人:Robert A Rissman
-
依托单位:
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
-
批准号:10360204
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2001
-
负责人:Robert A Rissman
-
依托单位:
a-Synuclein vulnerability mechanisms and therapeutics in Alzheimer's Disease
-
批准号:10232069
-
项目类别:
-
资助金额:$50.63万
-
财政年份:2001
-
负责人:Robert A Rissman
-
依托单位:
BIOMARKER CORE
-
批准号:8601648
-
项目类别:
-
资助金额:$21.7万
-
财政年份:--
-
负责人:Robert A Rissman
-
依托单位:
国内基金
海外基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
-
批准号:81000622
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:梁胜
-
依托单位:
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
-
批准号:31060293
-
项目类别:地区科学基金项目
-
资助金额:26.0万元
-
批准年份:2010
-
负责人:郭亚芬
-
依托单位:
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
-
批准号:30960334
-
项目类别:地区科学基金项目
-
资助金额:22.0万元
-
批准年份:2009
-
负责人:董贵成
-
依托单位: